These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28685000)

  • 1. Amphotericin B potentiates the anticancer activity of doxorubicin on the MCF-7 breast cancer cells.
    Tavangar F; Sepehri H; Saghaeian Jazi M; Asadi J
    J Chem Biol; 2017 Jul; 10(3):143-150. PubMed ID: 28685000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity.
    Bamodu OA; Huang WC; Tzeng DT; Wu A; Wang LS; Yeh CT; Chao TY
    Cancer Lett; 2015 Aug; 364(2):125-34. PubMed ID: 25976769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines.
    Ilisso CP; Castellano M; Zappavigna S; Lombardi A; Vitale G; Dicitore A; Cacciapuoti G; Caraglia M; Porcelli M
    Endocrine; 2015 Sep; 50(1):212-22. PubMed ID: 25577236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin potentiates doxorubicin activity against MCF-7 breast cancer cells.
    Buranrat B; Suwannaloet W; Naowaboot J
    Oncol Lett; 2017 Nov; 14(5):6243-6250. PubMed ID: 29113274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
    Muñoz-Gámez JA; Martín-Oliva D; Aguilar-Quesada R; Cañuelo A; Nuñez MI; Valenzuela MT; Ruiz de Almodóvar JM; De Murcia G; Oliver FJ
    Biochem J; 2005 Feb; 386(Pt 1):119-25. PubMed ID: 15456408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin.
    Quagliariello V; De Laurentiis M; Rea D; Barbieri A; Monti MG; Carbone A; Paccone A; Altucci L; Conte M; Canale ML; Botti G; Maurea N
    Cardiovasc Diabetol; 2021 Jul; 20(1):150. PubMed ID: 34301253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avoiding the Interference of Doxorubicin with MTT Measurements on the MCF-7 Breast Cancer Cell Line.
    Luis C; Castaño-Guerrero Y; Soares R; Sales G; Fernandes R
    Methods Protoc; 2019 Apr; 2(2):. PubMed ID: 31164609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death.
    Chiosi E; Spina A; Sorrentino A; Romano M; Sorvillo L; Senatore G; D'Auria R; Abbruzzese A; Caraglia M; Naviglio S; Illiano G
    J Interferon Cytokine Res; 2007 Jul; 27(7):589-97. PubMed ID: 17651020
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Farghadani R; Seifaddinipour M; Rajarajeswaran J; Abdulla MA; Mohd Hashim NB; Khaing SL; Salehen NB
    PeerJ; 2019; 7():e7686. PubMed ID: 31608167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-tocopheryl succinate enhances doxorubicin-induced apoptosis in human gastric cancer cells via promotion of doxorubicin influx and suppression of doxorubicin efflux.
    Zhang X; Peng X; Yu W; Hou S; Zhao Y; Zhang Z; Huang X; Wu K
    Cancer Lett; 2011 Aug; 307(2):174-81. PubMed ID: 21536373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel camptothecin derivative, CPT211, induces cell cycle arrest and apoptosis in models of human breast cancer.
    Chiu CF; Lin YQ; Park JM; Chen YC; Hung SW; Chiu CC; Chang CF
    Biomed Pharmacother; 2020 Aug; 128():110309. PubMed ID: 32505820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells.
    Jänicke RU; Engels IH; Dunkern T; Kaina B; Schulze-Osthoff K; Porter AG
    Oncogene; 2001 Aug; 20(36):5043-53. PubMed ID: 11526489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73.
    Tiwary R; Yu W; Sanders BG; Kline K
    Breast Cancer Res; 2011 Jan; 13(1):R1. PubMed ID: 21214929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.
    Kars MD; Iseri OD; Gündüz U; Ural AU; Arpaci F; Molnár J
    Anticancer Res; 2006; 26(6B):4559-68. PubMed ID: 17201178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. n-3 PUFAs synergistically enhance the efficacy of doxorubicin by inhibiting the proliferation and invasion of breast cancer cells.
    Gurav P; Patade T; Hajare S; Kedar RN
    Med Oncol; 2023 Nov; 41(1):2. PubMed ID: 38017288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Fucoidan and Chemotherapeutic Agent Combinations on Malignant and Non-malignant Breast Cell Lines.
    Abudabbus A; Badmus JA; Shalaweh S; Bauer R; Hiss D
    Curr Pharm Biotechnol; 2017; 18(9):748-757. PubMed ID: 29141543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenethyl isothiocyanate potentiates anti-tumour effect of doxorubicin through Akt-dependent pathway.
    Eisa NH; ElSherbiny NM; Shebl AM; Eissa LA; El-Shishtawy MM
    Cell Biochem Funct; 2015 Dec; 33(8):541-51. PubMed ID: 26548747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dichloromethane fractions of Scrophularia oxysepala extract induce apoptosis in MCF-7 human breast cancer cells.
    Hosseini BA; Pasdaran A; Kazemi T; Shanehbandi D; Karami H; Orangi M; Baradaran B
    Bosn J Basic Med Sci; 2015 Jan; 15(1):26-32. PubMed ID: 25725141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis.
    Yang XH; Sladek TL; Liu X; Butler BR; Froelich CJ; Thor AD
    Cancer Res; 2001 Jan; 61(1):348-54. PubMed ID: 11196185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsp90 Inhibitor; NVP-AUY922 in Combination with Doxorubicin Induces Apoptosis and Downregulates VEGF in MCF-7 Breast Cancer Cell Line.
    Mohammadian M; Feizollahzadeh S; Mahmoudi R; Toofani Milani A; Rezapour-Firouzi S; Karimi Douna B
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1773-1778. PubMed ID: 32592377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.